Evidence map›Paper›PMID 31554387›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2019

Evaluation of Patched-1 Protein Expression Level in Low Risk and High Risk Basal Cell Carcinoma Subtypes.

Rowida Almomani, Mariam Khanfar, Khaldon Bodoor, Firas Al-Qarqaz, Mohammad Alqudah, Hanan Hammouri, Asma Abu-Salah, Yazan Haddad, Wisam Al Gargaz, Ziyad Mohaidat

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Rowida AlmomaniDepartment of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid, Jordan. Email: rfalmomani7@just.edu.jo
Mariam KhanfarDepartment of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid, Jordan. Email: rfalmomani7@just.edu.jo
Khaldon BodoorDepartment of Applied Biology, Jordan University of Science and Technology, Irbid, Jordan.
Firas Al-QarqazDepartment of Dermatology, Jordan University of Science and Technology, Irbid, Jordan.
Mohammad AlqudahDepartment of Pathology, Jordan University of Science and Technology, Irbid, Jordan.
Hanan HammouriDepartment of Mathematics and Statistics, Faculty of Science and Arts, Jordan University of Science and Technology, Irbid, Jordan.
Asma Abu-SalahDepartment of Pathology, Jordan University of Science and Technology, Irbid, Jordan.
Yazan HaddadDepartment of Applied Biology, Jordan University of Science and Technology, Irbid, Jordan.
Wisam Al GargazOrthopedic Surgery Division, Special Surgery Department, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Ziyad MohaidatOrthopedic Surgery Division, Special Surgery Department, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Jordan University of Science and Technology · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Basal cell carcinoma (BCC) is the most common malignancy in humans and represents a growing public health care problem. The major etiological factors contributing to BCC development are exposure to ultraviolet radiation and genetic alterations. BCC is primarily caused by dysregulation of sonic Hedgehog (HH) signaling pathway in basal cells of the skin. BCC can be classified into low risk non-aggressive and high risk aggressive subtypes. BCC subtypes differentiation is essential for prognosis and for better disease management and treatment strategies. The aim of this study was to assess the correlation between PTCH1 protein expression level and the aggressiveness of BCC histopathology. Methods: Archival paraffin embedded blocks containing BCC were retrieved from a cohort of 101 patients. Immunohistochemistry staining was performed to assess the expression level of PTCH1 which is a key component of Hedgehog pathway. Results: 101 paraffin embedded samples were evaluated and classified as high risk and low risk BCC subtypes by histopathological finding. High risk BCC subtypes were found in 40 samples (39.6%) and low risk subtypes were identified in 61 samples (60.4%). Nodular was the most frequent subtype which was found in (56/ 101), followed by infiltrative (22/101) and micronodular (14/ 101) subtypes. Positive PTCH1 expression was found highest in nodular subtypes (46.5%). Conclusion: In this study, the correlation between low risk or high risk BCC subtypes and PTCH1 expression level was not statistically significant (p>0.05), but the frequency of positive PTCH1 expression was found to be higher in low risk subtypes than high risk BCC subtypes.

Indexed as

Basal Cell CarcinomaBiomarkers, TumorFemaleFollow-Up StudiesHumansMaleMiddle AgedPatched-1 ReceptorPrognosisRetrospective StudiesRisk FactorsBiomarkers, TumorPatched-1 ReceptorPTCH1 protein, humanBasal cell carcinomahigh risk BCClow risk BCCPTCH1

Identifiers

PMID31554387
PMCPMC6976826
OpenAlexW2975429137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.